Miller James Charles
Insider CIK 1846245 · REPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SCTL Societal CDMO, Inc. | D To issuer deriv | 2024-04-08 | 2024-04-08 | 118,182 | — | $0 | 0 | SEC↗ |
| SCTL Societal CDMO, Inc. | D To issuer deriv | 2024-04-08 | 2024-04-08 | 27,229 | — | $0 | 0 | SEC↗ |
| SCTL Societal CDMO, Inc. | D To issuer | 2024-04-08 | 2024-04-08 | 73,620 | $1.10 | $81.0K | 0 | SEC↗ |
| SCTL Societal CDMO, Inc. | U Tender | 2024-04-08 | 2024-04-08 | 153,923 | $1.10 | $169.3K | 73,620 | SEC↗ |
| SCTL Societal CDMO, Inc. | P Buy | 2023-08-28 | 2023-08-28 | 37,500 | $0.40 | $15.0K | 227,543 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 27,229 | — | $0 | 27,229 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award | 2023-05-17 | 2023-05-19 | 73,620 | — | $0 | 190,043 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award deriv | 2022-05-18 | 2022-05-20 | 118,182 | — | $0 | 118,182 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award | 2022-05-18 | 2022-05-20 | 87,500 | — | $0 | 116,423 | SEC↗ |
| SCTL Societal CDMO, Inc. | P Buy | 2022-03-18 | 2022-03-22 | 1,000 | $2.15 | $2.1K | 28,923 | SEC↗ |
| REPH Recro Pharma, Inc. | P Buy | 2021-11-17 | 2021-11-19 | 1,000 | $1.69 | $1.7K | 27,923 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2021-04-20 | 2021-04-22 | 38,012 | — | $0 | 38,012 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2021-04-20 | 2021-05-17 | 38,012 | — | $0 | 38,012 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2021-04-20 | 2021-04-22 | 26,923 | — | $0 | 26,923 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2021-02-09 | 2021-02-12 | 20,000 | — | $0 | 20,000 | SEC↗ |